Many types of mammalian cells, when placed into culture, halt proliferation and enter into a non-growing state termed senescence. The prevailing theory says that the onset of senescence is dictated by the length of double strand (ds) DNA regions of the telomeres at the ends of chromosomes. We have demonstrated that, on the contrary, senescence is not controlled by the overall length of the ds telomeric DNA, but instead by the length of a short stretch of single-strand DNA that protrudes from (overhangs) from the ends of the dsDNA portion of a telomere (ssOH). ssOH is largely lost when cells enter into senescence. We shall develop assays to gauge the lengths in situ of the ssOH and dsDNA portions. Using these assays as well as more direct molecular measurements, we will test a molecular model whereby physiologic stress suffered by cells provokes loss of the ssOH, and that this loss, in turn, induces a p53-dependent DNA damage response that results in the senescent cell phenotype. We will examine the notion that loss of the ssOH is a common mechanism for triggering senescence in response to a variety of physiologic stresses, and that this loss, is often provoked by cumulative oxidative damage suffered by cells. Use of in situ measurements of the ssOH and dsDNA portions of the telomeres within cells will allow us to determine whether the loss of ssOH occurs in a concerted fashion in individual cells and is thus actively provoked or in an asynchronous, stochastic fashion. In addition, these measurements will allow us to determine whether loss of ssOH and associated p53 activation occur in cells within living tissues, thereby providing evidence that the state of cell senescence occurs in vivo and may contribute to the loss of proliferative potential of cells in aging tissues and in various pathological states.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA078461-09
Application #
7227401
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Okano, Paul
Project Start
1999-09-30
Project End
2008-11-30
Budget Start
2007-06-01
Budget End
2008-11-30
Support Year
9
Fiscal Year
2007
Total Cost
$524,099
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Fröse, Julia; Chen, Michelle B; Hebron, Katie E et al. (2018) Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling. Cell Rep 24:962-972
Zhang, Yun; Weinberg, Robert A (2018) Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med 12:361-373
Keckesova, Zuzana; Donaher, Joana Liu; De Cock, Jasmine et al. (2017) LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature 543:681-686
Lambert, Arthur W; Pattabiraman, Diwakar R; Weinberg, Robert A (2017) Emerging Biological Principles of Metastasis. Cell 168:670-691
Bierie, Brian; Pierce, Sarah E; Kroeger, Cornelia et al. (2017) Integrin-?4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A 114:E2337-E2346
Pattabiraman, Diwakar R; Bierie, Brian; Kober, Katharina Isabelle et al. (2016) Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science 351:aad3680
De Cock, Jasmine M; Shibue, Tsukasa; Dongre, Anushka et al. (2016) Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency. Cancer Res 76:6778-6784
Pattabiraman, Diwakar R; Weinberg, Robert A (2016) Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy. Cold Spring Harb Symp Quant Biol 81:11-19
Ye, Xin; Weinberg, Robert A (2015) Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol 25:675-686
Chaffer, Christine L; Weinberg, Robert A (2015) How does multistep tumorigenesis really proceed? Cancer Discov 5:22-4

Showing the most recent 10 out of 44 publications